Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Original
1. Comparison of the efficacy of tadalafil in three different groups; patients on hemodialysis, first kidney transplant recipients, and second kidney transplant recipients
Mehdi Dehghani
, Amir-Hesam Alirezaei
, Amir Javid
, Nasrin Borumandnia
, Majid Aliasgari
, Farshad Gholipour*
J Renal Inj Prev
. 2023;12(3): e31952.
doi:
10.34172/jrip.2023.31952
Scopus ID:
85166310110
Article
PDF
XML
Cited By:
0
0
×
Comparison of the efficacy of tadalafil in three different groups; patients on hemodialysis, first kidney transplant recipients, and second kidney transplant recipients